Drägerwerk's Q3 2026 Results: Earnings Dip, Sales Rise

Drägerwerk AG & Co. KGaA announced preliminary figures for Q3 2026, revealing a mixed performance. Earnings before interest and taxes (EBIT) decreased to EUR 48 million from EUR 56.7 million the previous year, despite customs duty refunds of EUR 20.1 million. The EBIT margin dropped to 5.6% from 6.8% in 2025.

Net sales rose modestly by 2.1%, reaching EUR 851 million. The safety division saw a 5.3% increase in sales, while the medical division experienced a slight decline of 0.4%. The group's order intake improved by 8.2%, driven by strong demand in Germany, the Americas, and Asia-Pacific.

For the first nine months of 2026, Dräger recorded a 5.3% increase in net sales and a significant EBIT rise to EUR 112 million, thanks to customs duty refunds. The company maintains its forecast for a net sales increase of 2.0 to 6.0% and an EBIT margin of 6.0 to 8.0% for the year.